curasan AG signs sales agreement with Stryker S.A.
"Partnering with Stryker, a powerful global leader with experience in biologicals and biomaterials, opens up the highest-volume market segment for us, namely, orthopedics", stated curasan's CEO, Hans Dieter Rössler.
David Halliday, VP Spine, Biotech CMF with responsibility for these product lines across Europe similarly expressed his satisfaction with the new partnership: “Once Stryker Europe decided to commit to focusing its sales efforts on the high-growth biomaterials market, the joint venture with curasan was an excellent strategic match."
The two corporations are planning a long-term collaboration and the possible inclusion of future pipeline products from curasan AG in the agreement.
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.